Overadditive synergism between the intercalators mitoxantrone and lucanthone in advanced L 1210 and P 388 leukemia
- 1 April 1986
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 111 (2) , 137-140
- https://doi.org/10.1007/bf00400752
Abstract
The combination of mitoxantrone with lucanthone, a schistosomicidal and nonmyelotoxic agent, yielded a therapeutic synergism in L 1210 and P 388 leukemia with no increase in toxicity. In that combination the nonmyelotoxic lucanthone enabled the use of the optimal dose of mitoxantrone. The recent hypothesis that planar polycyclic aromatic compounds, mostly comprised by the term intercalators, intercalate with DNA or bind to DNA may need receiving with respect to membrane target sites.Keywords
This publication has 18 references indexed in Scilit:
- Membrane targets in cancer chemotherapyTrends in Pharmacological Sciences, 1984
- Biologic and biochemical effects of mitoxantrone.1984
- Molecular and biochemical pharmacology of mitoxantroneCancer Treatment Reviews, 1983
- Aza analogs of lucanthone: synthesis and antitumor and bactericidal propertiesJournal of Medicinal Chemistry, 1983
- Inhibition of adriamycin-stimulated microsomal lipid peroxidation by mitoxantrone and ametantrone, two new anthracenedione antineoplastic agentsBiochemical and Biophysical Research Communications, 1982
- The Anticancer Agent Adriamycin Can Be Actively Cytotoxic Without Entering CellsScience, 1982
- Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acidsBiochemical Pharmacology, 1981
- Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenedionesJournal of Medicinal Chemistry, 1979
- A Systematic Investigation of Thioxanthen-9-ones and Analogs as Potential Antitumor Agents1,2Journal of Medicinal Chemistry, 1963
- Untersuchungen über die tumorhemmende Wirkung des MiracilsThe Science of Nature, 1949